title: BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned.
authors.affiliation: Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.|University of Western Australia Medical School, Crawley, WA, Australia.|Fiona Stanley Hospital Urology, Murdoch, WA, Australia.
authors.forename: Dickon
authors.initials: D
authors.lastname: Hayne
authors.affiliation: Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.|NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
authors.forename: Martin
authors.initials: M
authors.lastname: Stockler
authors.affiliation: Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.|Fiona Stanley Hospital Urology, Murdoch, WA, Australia.
authors.forename: Steve P
authors.identifier: 0000-0002-3920-994X
authors.initials: SP
authors.lastname: McCombie
authors.affiliation: Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.|NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
authors.forename: Nicola
authors.initials: N
authors.lastname: Lawrence
authors.affiliation: Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.|NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
authors.forename: Andrew
authors.initials: A
authors.lastname: Martin
authors.affiliation: Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.|Department of Urology, Austin Health, Melbourne, Vic., Australia.|Austin Department of Surgery, University of Melbourne, Melbourne, Vic., Australia.|Ludwig Institute for Cancer Research, Austin Hospital, Melbourne, Vic., Australia.
authors.forename: Shomik
authors.initials: S
authors.lastname: Sengupta
authors.affiliation: Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia.|Monash University Eastern Health Clinical School, Box Hill, Vic., Australia.
authors.forename: Ian D
authors.initials: ID
authors.lastname: Davis
mesh_terms: D000283:Administration, Intravesical; D001315:Australia; D001500:BCG Vaccine / Q000008:administration & dosage*; D017326:Clinical Trials, Phase III as Topic; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage*; D009361:Neoplasm Invasiveness / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*
chemical_list: D001500:BCG Vaccine; D016685:Mitomycin